P2Y Receptors in Health and Disease

Advances in Pharmacology

Volumn 61, Issue , 2011, Pages 417-439

  Erlinge, David ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

ADP; ATP; Clinic; Drug; P2Y; Receptor; UDP; UTP

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BISPHOSPHONIC ACID DERIVATIVE; CHLORIDE; CLOPIDOGREL; COLLAGEN; CYCLIC AMP; CYCLOOXYGENASE 1; CYTOCHROME P450; CYTOCHROME P450 2C19; DENUFOSOL; ELINOGREL; FIBRINOGEN; FISH OIL; INTEGRIN; MULTIDRUG RESISTANCE PROTEIN 1; PRASUGREL; PURINERGIC P2X1 RECEPTOR; PURINERGIC P2Y RECEPTOR; REGRELOR; SEROTONIN 1D AGONIST; THROMBOXANE; TICAGRELOR; TICLOPIDINE; UNINDEXED DRUG; URIDINE DIPHOSPHATE; URIDINE TRIPHOSPHATE; VON WILLEBRAND FACTOR; WATER;

ACUTE CORONARY SYNDROME; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BOOK; CARDIOVASCULAR DISEASE; CYSTIC FIBROSIS; DRUG ELUTING STENT; DRUG RESISTANCE; DRY EYE; EYE DISEASE; HEART INFARCTION; HEART PROTECTION; HUMAN; LUNG DISEASE; MIGRAINE; MORTALITY; NONHUMAN; ONCOLOGY; OSTEOPOROSIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; STROKE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION;

EID: 79955975595     PISSN: 10543589     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-12-385526-8.00013-8     Document Type: Chapter

References (104)

1. Amisten S., Meidute-Abaraviciene S., Tan C., Olde B., Lundquist I., Salehi A., et al. ADP mediates inhibition of insulin secretion by activation of P2Y13 receptors in mice. Diabetologia 2010, 53(9):1927-1934.
2. Amisten S., Melander O., Wihlborg A.K., Berglund G., Erlinge D. Increased risk of acute myocardial infarction and elevated levels of C-reactive protein in carriers of the Thr-87 variant of the ATP receptor P2Y11. European Heart Journal 2007, 28(1):13-18.
3. Baricordi O.R., Ferrari D., Melchiorri L., Chiozzi P., Hanau S., Chiari E., et al. An ATP-activated channel is involved in mitogenic stimulation of human T lymphocytes. Blood 1996, 87(2):682-690.
4. Beijer S., Hupperets P.S., van den Borne B.E., Eussen S.R., van Henten A.M., van den Beuken-van Everdingen M., et al. Effect of adenosine 5'-triphosphate infusions on the nutritional status and survival of preterminal cancer patients. Anti-Cancer Drugs 2009, 20(7):625-633.
5. Berger P.B., Bell M.R., Rihal C.S., Ting H., Barsness G., Garratt K., et al. Clopidogrel versus ticlopidine after intracoronary stent placement. Journal of the American College of Cardiology 1999, 34(7):1891-1894.
6. Bertrand G., Chapal J., Puech R., Loubatieres-Mariani M.M. Adenosine-5'-O-(2-thiodiphosphate) is a potent agonist at P2 purinoceptors mediating insulin secretion from perfused rat pancreas. British Journal of Pharmacology 1991, 102(3):627-630.
7. Bjorkman J.-A., Kirk I., van Giezen J.J. AZD6140 inhibits adenosine uptake into erythrocytes and enhances coronary blood flow after local ischemia or intracoronary adenosine infusion. Circulation 2007, 116. :II_28.
8. Blachier F., Malaisse W.J. Effect of exogenous ATP upon inositol phosphate production, cationic fluxes and insulin release in pancreatic islet cells. Biochimica et Biophysica Acta 1988, 970(2):222-229.
9. Blom D., Yamin T.T., Champy M.F., Selloum M., Bedu E., Carballo-Jane E., et al. Altered lipoprotein metabolism in P2Y(13) knockout mice. Biochimica et Biophysica Acta 2010, 1801(12):1349-1360.
10. Borna C., Lazarowski E., van Heusden C., Ohlin H., Erlinge D. Resistance to aspirin is increased by ST-elevation myocardial infarction and correlates with adenosine diphosphate levels. Thrombosis Journal 2005, 3:10.
11. Braun O.O., Johnell M., Varenhorst C., James S., Brandt J.T., Jakubowski J.A., et al. Greater reduction of platelet activation markers and platelet-monocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease. Thrombosis and Haemostasis 2008, 100(4):626-633.
12. Brock J.A., Van Helden D.F. Enhanced excitatory junction potentials in mesenteric arteries from spontaneously hypertensive rats. Pflugers Archiv 1995, 430(6):901-908.
13. Brook M.M., Fineman J.R., Bolinger A.M., Wong A.F., Heymann M.A., Soifer S.J. Use of ATP-MgCl2 in the evaluation and treatment of children with pulmonary hypertension secondary to congenital heart defects. Circulation 1994, 90(3):1287-1293.
14. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996, 348(9038):1329-1339.
15. Chen Y.J., Hsu K.W., Chen Y.L. Acute glucose overload potentiates nitric oxide production in lipopolysaccharide-stimulated macrophages: The role of purinergic receptor activation. Cell Biology International 2006, 30(10):817-822.
16. Clemens M.G., Forrester T. Appearance of adenosine triphosphate in the coronary sinus effluent from isolated working rat heart in response to hypoxia. The Journal of Physiology 1981, 312:143-158.
17. Daniel J.L., Dangelmaier C., Jin J., Ashby B., Smith J.B., Kunapuli S.P. Molecular basis for ADP-induced platelet activation I. Evidence for three distinct ADP receptors on human platelets. The Journal of Biological Chemistry 1998, 273(4):2024-2029.
18. Dawicki D.D., McGowan-Jordan J., Bullard S., Pond S., Rounds S. Extracellular nucleotides stimulate leukocyte adherence to cultured pulmonary artery endothelial cells. The American Journal of Physiology 1995, 268(4 Pt 1):L666-L673.
19. Di Virgilio F., Solini A. P2 receptors: New potential players in atherosclerosis. British Journal of Pharmacology 2002, 135(4):831-842.
20. Duhant X., Schandene L., Bruyns C., Gonzalez N.S., Goldman M., Boeynaems J.M., et al. Extracellular adenine nucleotides inhibit the activation of human CD4+ T lymphocytes. Journal of Immunology 2002, 169(1):15-21.
21. Erlinge D., Burnstock G. P2 receptors in cardiovascular regulation and disease. Purinergic Signalling 2008, 4(1):85-87.
22. Erlinge D., Harnek J., van Heusden C., Olivecrona G., Jern S., Lazarowski E. Uridine triphosphate (UTP) is released during cardiac ischemia. International Journal of Cardiology 2005, 100(3):427-433.
23. Erlinge D., Varenhorst C., Braun O.O., James S., Winters K.J., Jakubowski J.A., et al. Patients with poor responsiveness to thienopyridine treatment or with diabetes have lower levels of circulating active metabolite, but their platelets respond normally to active metabolite added ex vivo. Journal of the American College of Cardiology 2008, 52(24):1968-1977.
24. Fabre J.E., Nguyen M., Latour A., Keifer J.A., Audoly L.P., Coffman T.M., et al. Decreased platelet aggregation, increased bleeding time and resistance to thromboembolism in P2Y1-deficient mice. Natural Medicines 1999, 5(10):1199-1202.
25. Farret A., Filhol R., Linck N., Manteghetti M., Vignon J., Gross R., et al. P2Y receptor mediated modulation of insulin release by a novel generation of 2-substituted-5'-O-(1-boranotriphosphate)-adenosine analogues. Pharmaceutical Research 2006, 23(11):2665-2671.
26. Fernandez O., Wangensteen R., Osuna A., Vargas F. Renal vascular reactivity to P(2)-purinoceptor activation in spontaneously hypertensive rats. Pharmacology 2000, 60(1):47-50.
27. Fernandez-Alvarez J., Hillaire-Buys D., Loubatieres-Mariani M.M., Gomis R., Petit P. P2 receptor agonists stimulate insulin release from human pancreatic islets. Pancreas 2001, 22(1):69-71.
28. Ferrari D., Chiozzi P., Falzoni S., Dal Susino M., Melchiorri L., Baricordi O.R., et al. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. Journal of Immunology 1997, 159(3):1451-1458.
29. Gaarder A., Jonsen J., Laland S., Hellem A., Owren P.A. Adenosine diphosphate in red cells as a factor in the adhesiveness of human blood platelets. Nature 1961, 192:531-532.
30. Galligan J.J., Hess M.C., Miller S.B., Fink G.D. Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats. The Journal of Pharmacology and Experimental Therapeutics 2001, 296(2):478-485.
31. Gordon J.L. Extracellular ATP: Effects, sources and fate. The Biochemical Journal 1986, 233(2):309-319.
32. Grapengiesser E., Dansk H., Hellman B. Pulses of external ATP aid to the synchronization of pancreatic beta-cells by generating premature Ca(2+) oscillations. Biochemical Pharmacology 2004, 68(4):667-674.
33. Grapengiesser E., Dansk H., Hellman B. External ATP triggers Ca2+ signals suited for synchronization of pancreatic beta-cells. The Journal of Endocrinology 2005, 185(1):69-79.
34. Greenberg B., Rhoden K., Barnes P.J. Endothelium-dependent relaxation of human pulmonary arteries. The American Journal of Physiology 1987, 252(2 Pt 2):H434-H438.
35. Gu B., Bendall L.J., Wiley J.S. Adenosine triphosphate-induced shedding of CD23 and L-selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 1998, 92(3):946-951.
36. Gurbel P.A., Becker R.C., Mann K.G., Steinhubl S.R., Michelson A.D. Platelet function monitoring in patients with coronary artery disease. Journal of the American College of Cardiology 2007, 50(19):1822-1834.
37. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. The New England Journal of Medicine 2005, 352(16):1685-1695.
38. Hashimoto M., Shinozuka K., Shahdat H.M., Kwon Y.M., Tanabe Y., Kunitomo M., et al. Antihypertensive effect of all-cis-5,8,11,14,17-icosapentaenoate of aged rats is associated with an increase in the release of ATP from the caudal artery. Journal of Vascular Research 1998, 35(1):55-62.
39. Hashimoto M., Shinozuka K., Tanabe Y., Shahdat H.M., Gamoh S., Kwon Y.M., et al. Long-term supplementation with a high cholesterol diet decreases the release of ATP from the caudal artery in aged rats. Life Sciences 1998, 63(21):1879-1885.
40. Hasko G., Cronstein B.N. Adenosine: An endogenous regulator of innate immunity. Trends in Immunology 2004, 25(1):33-39.
41. Hasko G., Linden J., Cronstein B., Pacher P. Adenosine receptors: Therapeutic aspects for inflammatory and immune diseases. Nature Reviews. Drug Discovery 2008, 7(9):759-770.
42. Hazama A., Hayashi S., Okada Y. Cell surface measurements of ATP release from single pancreatic beta cells using a novel biosensor technique. Pflugers Archiv 1998, 437(1):31-35.
43. Hechler B., Freund M., Ravanat C., Magnenat S., Cazenave J.P., Gachet C. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: The contribution of non-hematopoietic-derived P2Y1 receptors. Circulation 2008, 118(7):754-763.
44. Hellman B., Dansk H., Grapengiesser E. Pancreatic beta-cells communicate via intermittent release of ATP. American Journal of Physiology. Endocrinology and Metabolism 2004, 286(5):E759-E765.
45. Hillaire-Buys D., Chapal J., Bertrand G., Petit P., Loubatieres-Mariani M.M. Purinergic receptors on insulin-secreting cells. Fundamental & Clinical Pharmacology 1994, 8(2):117-127.
46. Hillarp A., Lethagen S., Mattiasson I. Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity. Journal of Thrombosis and Haemostasis 2003, 1(1):196-197.
47. Hollah P., Hausberg M., Kosch M., Barenbrock M., Letzel M., Schlatter E., et al. A novel assay for determination of diadenosine polyphosphates in human platelets: Studies in normotensive subjects and in patients with essential hypertension. Journal of Hypertension 2001, 19(2):237-245.
48. Hutton J.C., Penn E.J., Peshavaria M. Low-molecular-weight constituents of isolated insulin-secretory granules. Bivalent cations, adenine nucleotides and inorganic phosphate. The Biochemical Journal 1983, 210(2):297-305.
49. Idzko M., Dichmann S., Ferrari D., Di Virgilio F., la Sala A., Girolomoni G., et al. Nucleotides induce chemotaxis and actin polymerization in immature but not mature human dendritic cells via activation of pertussis toxin-sensitive P2y receptors. Blood 2002, 100(3):925-932.
50. Jankowski V., Tolle M., Vanholder R., Schonfelder G., van der Giet M., Henning L., et al. Uridine adenosine tetraphosphate: A novel endothelium-derived vasoconstrictive factor. Natural Medicines 2005, 11(2):223-227.
51. Jin J., Daniel J.L., Kunapuli S.P. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. The Journal of Biological Chemistry 1998, 273(4):2030-2034.
52. Jin J., Kunapuli S.P. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proceedings of the National Academy of Sciences of the United States of America 1998, 95(14):8070-8074.
53. Karoon P., Burnstock G. Reduced sympathetic noradrenergic neurotransmission in the tail artery of Donryu rats fed with high cholesterol-supplemented diet. British Journal of Pharmacology 1998, 123:1016-1021.
54. Kaufmann A., Musset B., Limberg S.H., Renigunta V., Sus R., Dalpke A.H., et al. "Host tissue damage" signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes. The Journal of Biological Chemistry 2005, 280(37):32459-32467.
55. Kawamura H., Aswad F., Minagawa M., Malone K., Kaslow H., Koch-Nolte F., et al. P2X7 receptor-dependent and -independent T cell death is induced by nicotinamide adenine dinucleotide. Journal of Immunology 2005, 174(4):1971-1979.
56. Kellerman D., Rossi Mospan A., Engels J., Schaberg A., Gorden J., Smiley L. Denufosol: A review of studies with inhaled P2Y(2) agonists that led to Phase 3. Pulmonary Pharmacology & Therapeutics 2008, 21(4):600-607.
57. Leon C., Hechler B., Freund M., Eckly A., Vial C., Ohlmann P., et al. Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y(1) receptor-null mice. Journal of Clinical Investigation 1999, 104(12):1731-1737.
58. Loubatieres-Mariani M.M., Chapal J., Lignon F., Valette G. Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. European Journal of Pharmacology 1979, 59(3-4):277-286.
59. Mahaut-Smith M.P., Tolhurst G., Evans R.J. Emerging roles for P2X1 receptors in platelet activation. Platelets 2004, 15(3):131-144.
60. Malmsjo M., Hou M., Pendergast W., Erlinge D., Edvinsson L. Potent P2Y6 receptor mediated contractions in human cerebral arteries. BMC Pharmacology 2003, 3:4.
61. Marteau F., Gonzalez N.S., Communi D., Goldman M., Boeynaems J.M. Thrombospondin-1 and indoleamine 2,3-dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 2005, 106(12):3860-3866.
62. Mega J.L., Close S.L., Wiviott S.D., Shen L., Hockett R.D., Brandt J.T., et al. Cytochrome p-450 polymorphisms and response to clopidogrel. The New England Journal of Medicine 2009, 360(4):354-362.
63. Mehta S.R., Bassand J.P., Chrolavicius S., Diaz R., Eikelboom J.W., Fox K.A., et al. Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. The New England Journal of Medicine 2010, 363(10):930-942.
64. Michelson A.D. How platelets work: Platelet function and dysfunction. Journal of Thrombosis and Thrombolysis 2003, 16(1-2):7-12.
65. Montalescot G., Wiviott S.D., Braunwald E., Murphy S.A., Gibson C.M., McCabe C.H., et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): Double-blind, randomised controlled trial. Lancet 2009, 373(9665):723-731.
66. Nilsson J., Nilsson L.M., Chen Y.W., Molkentin J.D., Erlinge D., Gomez M.F. High glucose activates nuclear factor of activated T cells in native vascular smooth muscle. Arteriosclerosis, Thrombosis, and Vascular Biology 2006, 26(4):794-800.
67. Parandeh F., Abaraviciene S.M., Amisten S., Erlinge D., Salehi A. Uridine diphosphate (UDP) stimulates insulin secretion by activation of P2Y6 receptors. Biochemical and Biophysical Research Communications 2008, 370(3):499-503.
68. Parodi J., Flores C., Aguayo C., Rudolph M.I., Casanello P., Sobrevia L. Inhibition of nitrobenzylthioinosine-sensitive adenosine transport by elevated D-glucose involves activation of P2Y2 purinoceptors in human umbilical vein endothelial cells. Circulation Research 2002, 90(5):570-577.
69. Peral A., Dominguez-Godinez C.O., Carracedo G., Pintor J. Therapeutic targets in dry eye syndrome. Drug News & Perspectives 2008, 21(3):166-176.
70. Petit P., Bertrand G., Schmeer W., Henquin J.C. Effects of extracellular adenine nucleotides on the electrical, ionic and secretory events in mouse pancreatic beta-cells. British Journal of Pharmacology 1989, 98(3):875-882.
71. Pham T.M., Morris J.B., Arthur J.F., Post G.R., Brown J.H., Woodcock E.A. UTP but not ATP causes hypertrophic growth in neonatal rat cardiomyocytes. Journal of Molecular and Cellular Cardiology 2003, 35(3):287-292.
72. Poulsen C.R., Bokvist K., Olsen H.L., Hoy M., Capito K., Gilon P., et al. Multiple sites of purinergic control of insulin secretion in mouse pancreatic beta-cells. Diabetes 1999, 48(11):2171-2181.
73. Romanello M., Bivi N., Pines A., Deganuto M., Quadrifoglio F., Moro L., et al. Bisphosphonates activate nucleotide receptors signaling and induce the expression of Hsp90 in osteoblast-like cell lines. Bone 2006, 39(4):739-753.
74. Salehi A., Qader S.S., Grapengiesser E., Hellman B. Inhibition of purinoceptors amplifies glucose-stimulated insulin release with removal of its pulsatility. Diabetes 2005, 54(7):2126-2131.
75. Sassmann A., Gier B., Grone H.J., Drews G., Offermanns S., Wettschureck N. The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice. Journal of Clinical Investigation 2010, 120(6):2184-2193.
76. Schluter H., Offers E., Bruggemann G., van der Giet M., Tepel M., Nordhoff E., et al. Diadenosine phosphates and the physiological control of blood pressure. Nature 1994, 367(6459):186-188.
77. Schmid-Antomarchi H., Schmid-Alliana A., Romey G., Ventura M.A., Breittmayer V., Millet M.A., et al. Extracellular ATP and UTP control the generation of reactive oxygen intermediates in human macrophages through the opening of a charybdotoxin-sensitive Ca2+-dependent K+ channel. Journal of Immunology 1997, 159(12):6209-6215.
78. Seiffert K., Ding W., Wagner J.A., Granstein R.D. ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. Journal of Investigative Dermatology 2006, 126(5):1017-1027.
79. Seye C.I., Kong Q., Erb L., Garrad R.C., Krugh B., Wang M., et al. Functional P2Y2 nucleotide receptors mediate uridine 5'-triphosphate-induced intimal hyperplasia in collared rabbit carotid arteries. Circulation 2002, 106(21):2720-2726.
80. Seye C.I., Yu N., Jain R., Kong Q., Minor T., Newton J., et al. The P2Y2 nucleotide receptor mediates UTP-induced vascular cell adhesion molecule-1 expression in coronary artery endothelial cells. The Journal of Biological Chemistry 2003, 278(27):24960-24965.
81. Solini A., Iacobini C., Ricci C., Chiozzi P., Amadio L., Pricci F., et al. Purinergic modulation of mesangial extracellular matrix production: Role in diabetic and other glomerular diseases. Kidney International 2005, 67(3):875-885.
82. Sprague R.S., Olearczyk J.J., Spence D.M., Stephenson A.H., Sprung R.W., Lonigro A.J. Extracellular ATP signaling in the rabbit lung: Erythrocytes as determinants of vascular resistance. American Journal of Physiology. Heart and Circulatory Physiology 2003, 285(2):H693-H700.
83. Sprague R.S., Stephenson A.H., Ellsworth M.L., Keller C., Lonigro A.J. Impaired release of ATP from red blood cells of humans with primary pulmonary hypertension. Experimental Biology and Medicine (Maywood) 2001, 226(5):434-439.
84. Squires P.E., James R.F., London N.J., Dunne M.J. ATP-induced intracellular Ca2+ signals in isolated human insulin-secreting cells. Pflugers Archiv 1994, 427(1-2):181-183.
85. Suzuki T., Hide I., Ido K., Kohsaka S., Inoue K., Nakata Y. Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. The Journal of Neuroscience 2004, 24(1):1-7.
86. Tan C., Salehi A., Svensson S., Olde B., Erlinge D. ADP receptor P2Y(13) induce apoptosis in pancreatic beta-cells. Cellular and Molecular Life Sciences 2010, 67(3):445-453.
87. Turner C.H., Robling A.G. Exercise as an anabolic stimulus for bone. Current Pharmaceutical Design 2004, 10(21):2629-2641.
88. Vassort G. Adenosine 5'-triphosphate: A P2-purinergic agonist in the myocardium. Physiological Reviews 2001, 81(2):767-806.
89. Vidal M., Hicks P.E., Langer S.Z. Differential effects of alpha-beta-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedeberg's Archives of Pharmacology 1986, 332(4):384-390.
90. Wallentin L., Becker R.C., Budaj A., Cannon C.P., Emanuelsson H., Held C., et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine 2009, 361(11):1045-1057.
91. Wallentin L., Varenhorst C., James S., Erlinge D., Braun O.O., Jakubowski J.A., et al. Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease. European Heart Journal 2008, 29:21-30.
92. Wang L., Jacobsen S.E., Bengtsson A., Erlinge D. P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells. BMC Immunology 2004, 5:16.
93. Wihlborg A.K., Balogh J., Wang L., Borna C., Dou Y., Joshi B.V., et al. Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circulation Research 2006, 98(7):970-976.
94. Wihlborg A.K., Wang L., Braun O.O., Eyjolfsson A., Gustafsson R., Gudbjartsson T., et al. ADP receptor P2Y12 is expressed in vascular smooth muscle cells and stimulates contraction in human blood vessels. Arteriosclerosis, Thrombosis, and Vascular Biology 2004, 24(10):1810-1815.
95. Wiviott S.D., Braunwald E., Angiolillo D.J., Meisel S., Dalby A.J., Verheugt F.W., et al. Greater clinical benefit of more intensive oral antiplatelet therapy with prasugrel in patients with diabetes mellitus in the trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in Myocardial Infarction 38. Circulation 2008, 118(16):1626-1636.
96. Wiviott S.D., Braunwald E., McCabe C.H., Montalescot G., Ruzyllo W., Gottlieb S., et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. The New England Journal of Medicine 2007, 357(20):2001-2015.
97. Yang D., Gluais P., Zhang J.N., Vanhoutte P.M., Feletou M. Endothelium-dependent contractions to acetylcholine, ATP and the calcium ionophore A 23187 in aortas from spontaneously hypertensive and normotensive rats. Fundamental & Clinical Pharmacology 2004, 18(3):321-326.
98. Yitzhaki S., Shainberg A., Cheporko Y., Vidne B.A., Sagie A., Jacobson K.A., et al. Uridine-5'-triphosphate (UTP) reduces infarct size and improves rat heart function after myocardial infarct. Biochemical Pharmacology 2006, 72(8):949-955.
99. Yitzhaki S., Shneyvays V., Jacobson K.A., Shainberg A. Involvement of uracil nucleotides in protection of cardiomyocytes from hypoxic stress. Biochemical Pharmacology 2005, 69(8):1215-1223.
100. Yusuf S., Zhao F., Mehta S.R., Chrolavicius S., Tognoni G., Fox K.K. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. The New England Journal of Medicine 2001, 345(7):494-502.
101. Zhang S., Remillard C.V., Fantozzi I., Yuan J.X. ATP-induced mitogenesis is mediated by cyclic AMP response element-binding protein-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells. American Journal of Physiology. Cell Physiology 2004, 287(5):C1192-C1201.
102. Zheng J.S., Boluyt M.O., Long X., O'Neill L., Lakatta E.G., Crow M.T. Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes. Circulation Research 1996, 78(4):525-535.
103. Zheng J.S., Boluyt M.O., O'Neill L., Crow M.T., Lakatta E.G. Extracellular ATP induces immediate-early gene expression but not cellular hypertrophy in neonatal cardiac myocytes. Circulation Research 1994, 74(6):1034-1041.
104. Zimmermann H. Ectonucleotidases in the nervous system. Novartis Foundation Symposium 2006, 276:113-128. discussion 128-130, 233-117, 275-181.